VP Biologics @ 上海睿智化学研究有限公司 (February 2010 - July 2013)
Associate Research Fellow, Volwiler Society, @ (January 2008 - February 2010)
Group leader @ (January 2005 - January 2008)
Senior Scientist @ (January 2003 - January 2005)
Scientist @ (January 2000 - January 2003)
Postdoc Fellow @ (January 1997 - January 2000)
Chengbin Wu Education
Harvard Medical School
Postdoc Fellow (Molecular Immunology)
1997-2000
The University of Georgia
Ph.D (Biochemistry and Moleculer Biology)
1993-1997
East China University of Science and Technology
B.E (Biochemical Engineering)
1985-1989
Chengbin Wu Skills
Antibodies
Biopharmaceuticals
Cell
Clinical Development
Drug Development
Drug Discovery
Immunology
Lifesciences
Pharmaceutical Industry
Protein Chemistry
Protein Engineering
R
Technology Transfer
Biochemistry
Assay Development
Biotechnology
Project Management
Microsoft Office
Business Strategy
Chengbin Wu Summary
Chengbin Wu, based in Shanghai, CN, is currently a CEO at EpimAb Biotherapeutics, Inc.. Chengbin Wu brings experience from previous roles at 上海中信国健药业股份有限公司, 上海睿智化学研究有限公司 and AbbVie. Chengbin Wu holds a 1997 - 2000 Postdoc Fellow in Molecular Immunology @ Harvard Medical School. With a robust skill set that includes Antibodies, Biopharmaceuticals, Cell, Clinical Development, Drug Development and more. Chengbin Wu has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Chengbin Wu?
Find contact details for 700 million professionals.